DRREDDY quarterly results and annual financials: sales, operating profit, OPM, net profit, EPS, balance sheet, cash flow and ratios like ROCE, with YoY and QoQ growth.
Dr Reddys Laboratories Ltd reported sales of ₹8,698 Cr, operating profit of ₹1,723 Cr (OPM 20%) and net profit of ₹913 Cr for the quarter ended Sep 2026. Figures in ₹ crore, consolidated where available.
DRREDDY quarterly results (₹ Cr)
Metric
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Sep 2026
Sales
8,381
8,528
8,572
8,828
8,753
7,546
8,100
8,698
Expenses
6,108
6,530
6,398
6,818
6,866
7,164
7,240
6,975
Operating Profit
2,273
1,998
2,174
2,010
1,888
382
860
1,723
OPM
27%
23%
25%
23%
22%
5%
11%
20%
Other Income
154
528
290
330
271
480
356
156
Interest
82
66
83
91
94
106
126
125
Depreciation
471
455
476
505
521
557
537
527
Profit before tax
1,874
2,005
1,905
1,745
1,543
200
553
1,228
Tax
25%
21%
26%
23%
23%
-11%
21%
26%
Net Profit
1,404
1,587
1,410
1,337
1,190
221
436
913
EPS in Rs
16.94
19.09
16.99
16.14
14.5
2.65
5.32
11.08
DRREDDY profit & loss, annual (₹ Cr)
Metric
Mar 2022
Mar 2023
Mar 2024
Mar 2025
Mar 2026
TTM
Sales
21,545
24,670
28,011
32,644
33,700
33,097
Expenses
17,778
18,200
20,078
24,097
27,247
28,245
Operating Profit
3,768
6,470
7,933
8,547
6,454
4,853
OPM
17%
26%
28%
26%
19%
15%
Other Income
555
971
909
1,119
1,372
1,263
Interest
96
143
171
283
374
450
Depreciation
1,165
1,250
1,470
1,704
2,059
2,141
Profit before tax
3,061
6,048
7,201
7,680
5,393
3,524
Tax
29%
25%
23%
25%
23%
-
Net Profit
2,182
4,507
5,578
5,725
4,158
2,760
EPS in Rs
26.23
54.14
66.87
67.77
50.27
33.55
Dividend Payout
23%
15%
12%
12%
16%
-
DRREDDY balance sheet (₹ Cr)
Metric
Mar 2024
Mar 2025
Sep 2025
Mar 2026
Sep 2026
Equity Capital
83
83
-
84
84
Reserves
28,171
33,466
-
37,808
38,724
Borrowings
2,002
4,677
-
7,734
7,229
Other Liabilities
8,523
9,797
-
10,951
11,596
Total Liabilities
38,780
48,023
-
56,577
57,631
Fixed Assets
10,426
18,226
-
22,063
22,173
CWIP
1,419
2,466
-
1,460
1,207
Investments
4,930
4,051
-
5,285
4,502
Other Assets
22,004
23,280
-
27,768
29,749
Total Assets
38,780
48,023
-
56,577
57,631
DRREDDY cash flows (₹ Cr)
Metric
Mar 2022
Mar 2023
Mar 2024
Mar 2025
Mar 2026
Cash from Operating Activity
2,811
5,888
4,543
4,643
5,674
Cash from Investing Activity
-2,565
-4,109
-4,034
-5,785
-6,425
Cash from Financing Activity
-242
-2,686
-376
1,891
829
Net Cash Flow
3
-907
133
749
78
Free Cash Flow
1,238
4,009
1,908
1,327
2,004
CFO/OP
94%
108%
83%
78%
109%
CFO/EBITDAShare of operating profit converting into cash: CFO (before tax) / Operating Profit